- Home
- PLX vs CCLD Comparison
PLX vs CCLD Comparison
Compare PLX & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- CCLD
- Stock Information
- Founded
- PLX 1993
- CCLD 1999
- Country
- PLX United States
- CCLD United States
- Employees
- PLX N/A
- CCLD N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- CCLD Computer Software: Prepackaged Software
- Sector
- PLX Health Care
- CCLD Technology
- Exchange
- PLX Nasdaq
- CCLD Nasdaq
- Market Cap
- PLX 122.6M
- CCLD 105.8M
- IPO Year
- PLX 1998
- CCLD 2014
- Fundamental
- Price
- PLX $1.54
- CCLD $2.49
- Analyst Decision
- PLX Strong Buy
- CCLD Buy
- Analyst Count
- PLX 1
- CCLD 2
- Target Price
- PLX $15.00
- CCLD $3.00
- AVG Volume (30 Days)
- PLX 1.2M
- CCLD 528.9K
- Earning Date
- PLX 08-13-2025
- CCLD 08-12-2025
- Dividend Yield
- PLX N/A
- CCLD N/A
- EPS Growth
- PLX N/A
- CCLD N/A
- EPS
- PLX 0.05
- CCLD N/A
- Revenue
- PLX $59,764,000.00
- CCLD $112,507,000.00
- Revenue This Year
- PLX $65.02
- CCLD $2.74
- Revenue Next Year
- PLX $57.34
- CCLD $7.52
- P/E Ratio
- PLX $31.98
- CCLD N/A
- Revenue Growth
- PLX 0.18
- CCLD N/A
- 52 Week Low
- PLX $0.82
- CCLD $1.14
- 52 Week High
- PLX $3.10
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- PLX 47.41
- CCLD 57.89
- Support Level
- PLX $1.32
- CCLD $2.26
- Resistance Level
- PLX $1.67
- CCLD $2.47
- Average True Range (ATR)
- PLX 0.11
- CCLD 0.17
- MACD
- PLX 0.04
- CCLD -0.01
- Stochastic Oscillator
- PLX 62.86
- CCLD 76.05
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.